Romano, Eugenia (2021) Engineered Extracellular Vesicles: Processing and testing of cell-derived Exos. [Tesi di dottorato]

[thumbnail of Eugenia_Romano_33.pdf]
Anteprima
Testo
Eugenia_Romano_33.pdf

Download (19MB) | Anteprima
Tipologia del documento: Tesi di dottorato
Lingua: English
Titolo: Engineered Extracellular Vesicles: Processing and testing of cell-derived Exos
Autori:
Autore
Email
Romano, Eugenia
eugenia.romano1@gmail.com
Data: 15 Luglio 2021
Numero di pagine: 132
Istituzione: Università degli Studi di Napoli Federico II
Dipartimento: Ingegneria Chimica, dei Materiali e della Produzione Industriale
Dottorato: Ingegneria dei prodotti e dei processi industriali
Ciclo di dottorato: 33
Coordinatore del Corso di dottorato:
nome
email
D'Anna, Andrea
anddanna@unina.it
Tutor:
nome
email
Torino, Enza
[non definito]
Netti, Paolo Antonio
[non definito]
Data: 15 Luglio 2021
Numero di pagine: 132
Parole chiave: Exosomes, Extracellular Vesicles, drug delivery, personalized medicine
Settori scientifico-disciplinari del MIUR: Area 09 - Ingegneria industriale e dell'informazione > ING-IND/34 - Bioingegneria industriale
Depositato il: 20 Lug 2021 12:48
Ultima modifica: 07 Giu 2023 11:24
URI: http://www.fedoa.unina.it/id/eprint/13590

Abstract

In recent decades, endogenous nanocarrier-exosomes have received considerable scientific interest as drug delivery systems. The unique proteo-lipid architecture allows the crossing of various natural barriers and protects Exosomes cargo from degradation in the bloodstream. However, the presence of this bilayer membrane as well as their endogenous content make production and loading of exogenous molecules challenging. In the present work, we will investigate how to promote the manipulation of cellular. And vesicles curvature by a high pressure microfluidic system as ground-breaking method for both Exosomes production and encapsulation. First of all, we exploited this approach to isolate the Exosomes derived by Glioblastoma U87-MG tumoral cell line. An increased yield and purity of Exosomes have been obtained. Furthermore, we proposed a complete protein-profiling comparing traditional isolation method in cell medium and isolation by Dynamic High-Pressure Homogenization. To validate our approach for Exosomes encapsulation, we tested in vitro the prodrug Irinotecan (IRI) in U87-MG Exosomes. As a result, we obtained a high EE, up to 45%, comparable to the principal industrial methodologies used for polymer nanoparticles, shortening the processing time for the encapsulation to several days to 1 hr, improving the drug uptake, and entirely avoiding the use of permeabilization enhancers. Also, this new approach has been tested on Doxorubicin and validated on a different cell lines and 3D cells model. Finally, we performed in vitro preliminary analysis to further understand Exosomes fate and nanobiointeraction with biological environment.

Downloads

Downloads per month over past year

Actions (login required)

Modifica documento Modifica documento